New Topic Post Reply Printable Version
[ << Previous Thread | Next Thread >> ]

Regular Member

Date Joined Jan 2010
Total Posts : 448
   Posted Today 12:31 PM (GMT -6)   
Additional Xifaxan Indication and Dosage Strength Approved

3/26/2010 7:42:08 AM

The FDA has approved Salix Pharmaceuticals’ Xifaxan (rifaximin) 550 mg tablets for the risk reduction of overt hepatic encephalopathy recurrence in patients 18 years of age and older. The medication is also indicated for the treatment of traveler's diarrhea caused by noninvasive strains of Escherichia coli in patients 12 years of age and older. The company expects to begin shipping the product in early May 2010
Male, 22. Diagnosed with Crohn's officially since 2001.. Osteoporosis, Generalized Anxiety Disorder, Chronic Anemia.

Medications Used: Remicade, Humira, Cimzia, 6-mp, Pentasa, Flagyl, Prednisone, Zifaxan, Entocort,
TPN (Total Parenteral Nutrition), The whole nine.

Current: Methotrexate Injection, Entocort EC, Vitamin D, Fentanyl 25mcg / 72hrs - Zofran - Folic Acid
Currently On SSDI

New Topic Post Reply Printable Version
Forum Information
Currently it is Sunday, March 26, 2017 4:54 PM (GMT -6)
There are a total of 2,782,226 posts in 305,752 threads.
View Active Threads

Who's Online
This forum has 152078 registered members. Please welcome our newest member, tjsloan.
462 Guest(s), 7 Registered Member(s) are currently online.  Details
clo2014, abb, hornet599, Serenity Now, summer16, sfc425, MitzMN

Follow on Facebook  Follow on Twitter  Follow on Pinterest

©1996-2017 LLC  All rights reserved.

Advertise | Privacy Policy & Disclaimer